期刊文献+

hTERT和survivin双靶点RNAi表达载体的构建及对人结肠癌SW480细胞的抑制作用 被引量:1

Construction of double interference vector targeting both survivin and hTERT gene and its inhibitory effect on human colon cancer cell line SW480
暂未订购
导出
摘要 目的构建人端粒酶反转录酶(hTERT)和生存素(survivin)基因表达的RNA共干扰载体,并检测其对人结肠癌SW480细胞中hTERT基因和survivin基因的干扰作用。方法根据Genbank提供的hTERT和survivin cDNA序列,设计、筛选出高效、特异性强的干扰序列,构建特异性干扰hTERT基因和survivin基因的重组体pGenesil-1.1-survivin、pGenesil-1.2-hTERT,酶切、测序鉴定正确后,两个重组体均用HindⅢ和BamHⅠ双酶切,将pGenesil-1.1-survivin回收大片段,pGenesil-1.2-hTERT回收小片段,将回收大、小片段用T4 DNA连接酶定向连接,即构建成重组体pGenesil1.1-survivin-hTERT。将3个重组体分别转染SW480细胞,RT-PCR检测细胞中hTERT和survivin基因表达水平,MTT检测对SW480细胞增殖的影响。结果构建的各质粒经限制性酶切及DNA测序均证明其质粒构建正确,RT-PCR检测hTERT和survivin基因表达水平明显降低(P<0.05),各干扰质粒重组体对细胞增殖有明显的抑制作用(P<0.05)。结论靶向survivin和hTERT基因的双干扰载体构建成功,为后续的结肠癌基因治疗研究奠定理论基础。 Objective To construct the double interference vector targeting both survivin and hTERT gene and de- tect its silencing effects on survivin and hTERT gene in human colon carcinoma SW480 cell line. Methods Two effective targeting sequences were chosen according to hTERT and survivin cDNA sequences in Gen Bank, Then they were inserted into pGenesil-1.1 and pGenesil-1.2, pGenesil-1.1-survivin and pGenesil-1.2-hTERT were con- structed. The recombinant plasmids were identified by restriction endonuclease and DNA sequencing, pGenesil- 1. 1-survivin and pGenesil-1.2-hTERT were digested by Hind 111 and BamH I se sil-1.1-survivin and small fragment of pGenesil-1.2-hTERT were collected. Then parately, long fragment of pGene- long fragment and small fragment were connected with T4 DNA ligase orientation, the double interference vector pGenesill. 1-survivin-hTERT wasconstructed. These siRNA recombinant expression vector separately were transfected into SW480 cell line, The effect of siRNA recombinant expression vector was detected by RT-PCR and MTT. Results By restriction endonuclease and DNA sequencing, specific RNAi expression vector targeting survivin and hTERT gene was correctly constructed. The growth rate of SW480 cells transfected with siRNA recombinant expression vector was significantly decreased. Conclu- sions The multiple siRNA recombinant expression vector targeting hTERT and survivin gene simultaneously has been constructed successfully. This result could provide theoretical information for the further research.
出处 《基础医学与临床》 CSCD 北大核心 2013年第11期1440-1445,共6页 Basic and Clinical Medicine
基金 国家自然科学基金(30901779) 潍坊市科技局资助项目(20121227) 山东省自然科学基金(ZR2010HM065 ZR2010HM006)
关键词 双靶点RNA干扰 SURVIVIN HTERT double inierferenee siRNA survivin hTERT
  • 相关文献

参考文献10

  • 1Shammas MA, Koley H, Batchu RB, et al. Telomerase in- hibition by siRNA causes senescence and apoptosis in Barrett's adenoearcinoma cells: mechanism and therapeutic potential. [J]. Mol Cancer,2005, 4: 24.
  • 2Mita AC, Mita MM, Nawrocki ST,et al. Survivin : key regu- lator of mitosis and apoptosis and novel target for cancer ther- apeutics [J]. Clin Cancer Res, 2008, 14:5000-5005.
  • 3薛芳,段明英,陈燕.RNAi抑制Survivin基因表达增加细胞凋亡[J].基础医学与临床,2009,29(9):965-969. 被引量:2
  • 4Hanahan D, Weinberg RA. The hallmarks of cancer [ J ]. Cell, 2000, 100:57-70.
  • 5丁明霞,李翀,左毅刚,王剑松.CD44 RNAi对EJ细胞增殖、迁移及其与特异性单抗结合力的影响[J].基础医学与临床,2012,32(3):313-316. 被引量:3
  • 6Jazag A, Kanai F, Ijichi H, et al. Single small-interfering RNA expression vector for silencing multiple transforming growth factor-beta pathway components [ J ]. Nucleic Acids Res,2005, 33 :el31.
  • 7Hu T, Fu Q, Chen P, et al. Construction of an artificial MicroRNA expression vector for simultaneous inhibition of multiple genes in mammalian cells [ J ]. Int J Mol Sci,2009,10:2158 - 2168.
  • 8Junn HJ, Kirn JY, Seol DW. Effective knockdown of multi- ple target genes by expressing the single transcript harbou- ring rnulti-cistronic shRNAs [ J]. Biochem Biophys Res Comrnun, 2010, 396:861 - 865.
  • 9Kumari A, Srinivasan R, Wig JD. Effect of c-MYC and E2F1 gene silencing and of 5-azacytidine treatment on te- lomerase activity in pancreatic cancer-derived cell lins [J]. Pancreatology, 2009, 9:360 - 368.
  • 10Yuan J, Yang BM, Zhong ZH, et al. Upregulation of sur- vivin during immortalization of nontransformed human fi- broblasts transduced with telomerase reverse transcriptase [ J ]. Oncogene, 2009,28:2678 - 2689.

二级参考文献16

  • 1Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J]. Nature, 1998, 391:806 - 811.
  • 2Jimenez LG, Aguilar MC, Monroy OL, et al. Detection of autoantibodies to survivin in cervical mucus from patients with human papillomavims-associated cervical cancer and precursor lesions [ J ]. Autoimmunity, 2007, 40 ( 1 ) : 66 - 72.
  • 3Wang Rui, Lin Fang, Wang Xi, et al. The therapeutic potential of survivin promoter-driven siRNA on suppressing tumor growth and enhancing radiosensitivity of human cervical carcinoma cells via downregulating hTERT gene expression[J]. Cancer Biol Ther, 2007, 6(8) :1295 -1301.
  • 4Li F,Ambrosini G,Chu EY,et al. Control of apoptosis and mitotic spindle checkpoint by Survivin [ J ]. Nature, 1998, 396 (6711 ) :580 - 584.
  • 5Skoufias DA, Mollinari C, Lacroix FB, et al. Human Survivin is a kinetochore-associated passenger protein [ J ]. J Cell Biol, 2000, 151:1575 - 1582.
  • 6Fukada K, Takahashi-Yanaga F, Sakoguchi-Okada N, et al. Celecoxib induces apoptosis by inhibiting the expression of survivin in HeLa cells[ J ]. Biochem Biophys Res Commun, 2007,357(4) :1166 - 1171.
  • 7Jacobs BL,Lee CT,Montie JE.Bladder Cancer in 2010:How Far have We Come?[J].CA Cancer J Clin,2010,60:244-272.
  • 8Gallagher DJ,Milowsky MI,Gerst SR,et al.Phase II studyof sunitinib in patients with metastatic urothelial cancer[J].J Clin Oncol,2010,28:1373-1379.
  • 9Mitra,AP,Cote,RJ.Molecular pathogenesis and diagnos-tics of bladder cancer[J].Annu Rev Pathol,2009,4:251-285.
  • 10Bourguignon LY,Gilad E,Rothman K,et al.Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERKsignaling,leading to actin binding,Elk-1/estrogen receptortranscriptional activation,and ovarian cancer progression[J].J Biol Chem,2005,280:11961-11972.

共引文献3

同被引文献13

  • 1Siegel R, DeSantis C, Virgo K, el al. Cancer treatment and survivorship statistics, 2012 [ J ]. CA Cancer J Clin, 2012,62:220-241.
  • 2Ahieri D C. survivin, cancer networks and pathway-directed drug discovery[ J]. Nat Rev Cancer,2008,8:61-70.
  • 3Soong R,Shah N,Peh B K,et al. The expression of RUNX3 in colorectal cancer is bassociated with disease stage and patient outcome[ J]. Br J Cancer,2009,100:676-679.
  • 4Cheng XL, Li MK. Effect of topiramate on apoptosis-related protein expression of hippocampus in model rats with Alzhe- imers disease[J]. Eur Rev Med Pharmacol Sci, 2014,18: 761-768.
  • 5Boykin C, Zhang G, Chen YH, et al. Cucurbitacin Ila:a no- vel class of anti-cancer drug inducing non-reversible actinaggregation and inhibiting survivin independent of JAK2! STAT3 phosphorylation [ J ]. Br J Cancer, 2012, 106: 1248-1250.
  • 6Chen JS, Chen KT, Fan WC ,et al. Combined analysis of sur- vivin autoantibody and careinoemb ryonic antigen biomark- ers for improved detection of eolorectal cancer [ J ]. Clin Chem Lab Med,2010,48:719-725.
  • 7Barges Bdo N,Burbano RR, Harada ML. survivin-31C/G polymorphism and gastric cancer risk in a Brazilian popu- lation [ J ]. Clin Exp Med, 2011,11 : 189-193.
  • 8Kawata N, Tsuchiya N, Hofikawa Y, et al. Two survivin pol- ymorphisms are cooperatively associated with bladder canc- er susceptibility[ J]. Int J Cancer,2011,129 : 1872-1880.
  • 9杨东东,武雪亮,何琨,贾光辉,王立坤.Survivin在结直肠腺癌、腺瘤和癌旁正常组织中的表达及临床意义[J].军事医学,2013,37(7):525-528. 被引量:2
  • 10贾光辉,薛军,武雪亮,赵秀芳,白睿.RUNX3、Survivin在结直肠腺癌、腺瘤、正常黏膜中表达的临床意义[J].安徽医科大学学报,2013,48(10):1228-1232. 被引量:8

引证文献1

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部